Mechanistically, we found that H19 promoted hepatic steatosis by up‐regulating and the mTORC1 signalling axis (including active RAPTOR, mTOR, S6K SREBP and suppress LIPIN1) and MLXIPL transcriptional network in hepatocytes (Figure 7D). Here, MLXIPL is linked to fatty liver disease.